Table 1.
Clinical pathological characteristics | Cy0 and P0 (n = 19) | Cy+ or P+ (n = 13) | P |
---|---|---|---|
Age* | 76.3 ± 5.3 | 71± 12.7 | N.S |
Gender | |||
Male | 10 (52.6%) | 8 (61.5%) | N.S |
Female | 9 (47.4%) | 5 (38.5%) | |
N/L** | 2.7 (1.2-22) | 29 (1.6-5.7) | N.S |
P/L** | 136.4 (58.11-342.9) | 144.1 (89.71-255-9) | N.S |
L/M** | 2.45 (0.97-6.68) | 2.92 (1.14.03) | N.S |
Surgery*** | |||
Subtotal | |||
Gastrectomy GaGastrectomy | 7 (36.9%) | 8 (61.5%) | N.S |
Total | |||
Gastrectomy | 11 (57.9%) | 5 (38.5%) | |
Lymphoadenectomy | |||
Level***: | |||
D1 | 2 (10.5%) | 2 (15.5%) | N.S |
D2 | 11 (57.9%) | 9 (69,2%) | |
D2+ | 6 (31.6%) | 1 (7,7%) | |
Lauren Hystotype***: | |||
Intestinal | 13 (68.4%) | 6 (46.2%) | N.S |
Diffuse | 4 (21.1%) | 6 (46,2%) | |
Mixed | 1 (5.3%) | 1 (7.6%) | |
Signet Ring Cell: | |||
Yes | 1 (5.3%) | 2 (15.4%) | N.S |
No | 18 (94.7%) | 11 (84.6%) | |
pT | |||
2 | 3 (15.8%) | 1 (7.6%) | |
3 | 9 (47.4%) | 3 (23.1%) | N.S |
4a | 5 (26.3%) | 7 (53.8%) | |
4b | 2 (10.5%) | 2 (15.5%) | |
pN | |||
0 | 5 (26.3%) | 1 (7.6%) | |
1 | 1 (5.3%) | 1 (7.6%) | |
2 | 3 (15.8%) | 4 (30.8%) | N.S |
3a | 5 (26.3%) | 2 (15.5%) | |
3b | 5 (26.3%) | 5 (38.5%) | |
Stage | |||
I | 1 (5.4%) | 0 | |
II | 4 (21.0%) | 0 | |
IIIa | 4 (21.0%) | 0 | < 0.0001 |
IIIb | 6(31.6) | 0 | |
IIIc | 4 (21.0%) | 0 | |
IV | 0 | 13 (100%) | |
Lymphonodal Harvasted | 46 (8-126) | 34 (15-44) | 0.05 |
Ln ratio | 0.18 (0-0.85) | 0.20 (0-0.75) | n.s |
Veno-Lymp. Invasion | |||
Yes | 17 (89.5%) | 11 (84.6%) | |
No | 2 (10.5%) | 1 (76%) | n.s |
Periner. Invasion | |||
Yes | 13 (68.4%) | 10 ( 76.9%) | n.s |
No | 2 (10.5%) | 3 (23.1%) |
Patients were subdivided according to the presence or not of peritoneal disease (Cyoand Povs. Cy+ or P+). * Mean and SD; **Median values and range; ***data of Lauren classification were missed in one patient from each group. ns, not statistic.